{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:34:48Z","timestamp":1791495288802,"version":"4.3.4"},"reference-count":88,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Intramural Research Program of the NIH"}],"content-domain":{"domain":["clinicalkey.jp","surgpath.theclinics.com","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.path.2018.02.009","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T22:07:35Z","timestamp":1525817255000},"page":"297-311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Recent Advances in the Histopathology of Drug-Induced Liver Injury"],"prefix":"10.1016","volume":"11","author":[{"given":"David E.","family":"Kleiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.path.2018.02.009_bib1","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/hep.28323","article-title":"Categorization of drugs implicated in causing liver injury: critical assessment based on published case reports","volume":"63","author":"Bjornsson","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.path.2018.02.009_bib2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/jhep.2002.34857","article-title":"Incidence of drug-induced hepatic injuries: a French population-based study","volume":"36","author":"Sgro","year":"2002","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.path.2018.02.009_bib3","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland","volume":"144","author":"Bjornsson","year":"2013","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.path.2018.02.009_bib4","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","article-title":"Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States","volume":"135","author":"Chalasani","year":"2008","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.path.2018.02.009_bib5","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period","volume":"129","author":"Andrade","year":"2005","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.path.2018.02.009_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/cld.371","article-title":"Liver histology in the diagnosis and prognosis of drug-induced liver injury","volume":"4","author":"Kleiner","year":"2014","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.path.2018.02.009_bib7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/archinte.1965.03860140008003","article-title":"Drug-induced liver disease: a penalty for progress","volume":"115","author":"Popper","year":"1965","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.path.2018.02.009_bib8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.26709","article-title":"Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations","volume":"59","author":"Kleiner","year":"2014","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.path.2018.02.009_bib9","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","article-title":"Features and outcomes of 899 patients with drug-induced liver injury: The DILIN prospective study","volume":"148","author":"Chalasani","year":"2015","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.path.2018.02.009_bib10","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2010.11.006","article-title":"Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver","volume":"54","author":"Begriche","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.path.2018.02.009_bib11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1089-3261(05)70028-3","article-title":"Drug-induced hepatic vascular abnormalities","volume":"2","author":"Gitlin","year":"1998","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.path.2018.02.009_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00005176-198601000-00008","article-title":"Hepatomegaly following short-term high-dose steroid therapy","volume":"5","author":"Iancu","year":"1986","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"4","key":"10.1016\/j.path.2018.02.009_bib13","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/00000478-200604000-00012","article-title":"Glycogenic hepatopathy: an underrecognized hepatic complication of diabetes mellitus","volume":"30","author":"Torbenson","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2018.02.009_bib14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0022-3476(80)80123-5","article-title":"The effects of phenobarbital and diphenylhydantoin on liver function and morphology","volume":"97","author":"Aiges","year":"1980","journal-title":"J\u00a0Pediatr"},{"issue":"9","key":"10.1016\/j.path.2018.02.009_bib15","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/01.pas.0000208896.92988.fc","article-title":"Glycogen pseudoground glass change in hepatocytes","volume":"30","author":"Wisell","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2018.02.009_bib16","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/j.gastro.2006.07.006","article-title":"Ground-glass, polyglucosan-like hepatocellular inclusions: a \u201cnew\u201d diagnostic entity","volume":"131","author":"Lefkowitch","year":"2006","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.path.2018.02.009_bib17","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.23696","article-title":"Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop","volume":"52","author":"Fontana","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.path.2018.02.009_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cgh.2016.05.043","article-title":"Features of autoimmune hepatitis in patients with drug-induced liver injury","volume":"15","author":"de Boer","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.path.2018.02.009_bib19","first-page":"261","article-title":"Dietary supplement use in the United States, 2003-2006","volume":"141","author":"Bailey","year":"2011","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.path.2018.02.009_bib20","unstructured":"Dietary supplements Silver Spring, MD: U.S. Food and Drug Administration. 2017. Available at: https:\/\/www.fda.gov\/Food\/DietarySupplements\/default.htm. Accessed September 5, 2017."},{"issue":"4","key":"10.1016\/j.path.2018.02.009_bib21","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/hep.27317","article-title":"Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network","volume":"60","author":"Navarro","year":"2014","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.path.2018.02.009_bib22","first-page":"932","article-title":"Hepatoportal sclerosis related to the use of herbals and nutritional supplements. Causality or coincidence?","volume":"15","author":"Rios","year":"2016","journal-title":"Ann Hepatol"},{"issue":"1","key":"10.1016\/j.path.2018.02.009_bib23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jhep.2008.08.017","article-title":"Severe hepatotoxicity following ingestion of Herbalife nutritional supplements contaminated with Bacillus subtilis","volume":"50","author":"Stickel","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.path.2018.02.009_bib24","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1007\/s10620-016-4181-7","article-title":"Severe acute hepatocellular injury attributed to OxyELITE Pro: a case series","volume":"61","author":"Heidemann","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"12","key":"10.1016\/j.path.2018.02.009_bib25","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1007\/s10620-014-3221-4","article-title":"Experience with OxyELITE pro and acute liver injury in active duty service members","volume":"59","author":"Foley","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.path.2018.02.009_bib26","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1136\/bmj.e468","article-title":"Cholestasis secondary to anabolic steroid use in young men","volume":"344","author":"Elsharkawy","year":"2012","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.path.2018.02.009_bib27","doi-asserted-by":"crossref","first-page":"e844","DOI":"10.7205\/MILMED-D-14-00654","article-title":"Case report of supplement-induced hepatitis in an active duty service member","volume":"180","author":"Brazeau","year":"2015","journal-title":"Mil Med"},{"issue":"6","key":"10.1016\/j.path.2018.02.009_bib28","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1053\/j.gastro.2012.07.004","article-title":"Hepatic failure during anabolic steroid therapy","volume":"143","author":"Kou","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.path.2018.02.009_bib29","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1055\/s-2008-1040724","article-title":"Hepatic lesions caused by anabolic and contraceptive steroids","volume":"1","author":"Ishak","year":"1981","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.path.2018.02.009_bib30","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.mehy.2016.06.004","article-title":"Anabolic androgenic steroid-induced hepatotoxicity","volume":"93","author":"Bond","year":"2016","journal-title":"Med Hypotheses"},{"issue":"8","key":"10.1016\/j.path.2018.02.009_bib31","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/liv.12216","article-title":"Hepatotoxicity from anabolic androgenic steroids marketed as dietary supplements: contribution from ATP8B1\/ABCB11 mutations?","volume":"33","author":"El Sherrif","year":"2013","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.path.2018.02.009_bib32","first-page":"55","article-title":"Methylprednisolone-induced liver injury: case report and literature review","volume":"17","author":"Davidov","year":"2016","journal-title":"J\u00a0Dig Dis"},{"issue":"2","key":"10.1016\/j.path.2018.02.009_bib33","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/liv.12607","article-title":"Incomplete septal cirrhosis after high-dose methylprednisolone therapy and regression of liver injury","volume":"35","author":"Grilli","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.path.2018.02.009_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-210722","article-title":"Induced liver injury after high-dose methylprednisolone in a patient with multiple sclerosis","volume":"2015","author":"Oliveira","year":"2015","journal-title":"BMJ Case Rep"},{"issue":"4","key":"10.1016\/j.path.2018.02.009_bib35","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00228-013-1632-3","article-title":"Methylprednisolone-induced hepatotoxicity: experiences from global adverse drug reaction surveillance","volume":"70","author":"Caster","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.path.2018.02.009_bib36","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/BF03345386","article-title":"Autoimmune hepatitis during intravenous glucocorticoid pulse therapy for Graves' ophthalmopathy treated successfully with glucocorticoids themselves","volume":"28","author":"Marino","year":"2005","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"5","key":"10.1016\/j.path.2018.02.009_bib37","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.cgh.2012.12.025","article-title":"Liver injury from tumor necrosis factor-alpha antagonists: analysis of thirty-four cases","volume":"11","author":"Ghabril","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.path.2018.02.009_bib38","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.cgh.2014.07.062","article-title":"Risk of drug-induced liver injury from tumor necrosis factor antagonists","volume":"13","author":"Bjornsson","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.path.2018.02.009_bib39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s13256-015-0730-5","article-title":"Infliximab-associated fulminant hepatic failure in ulcerative colitis: a case report","volume":"9","author":"Parra","year":"2015","journal-title":"J\u00a0Med Case Rep"},{"issue":"24","key":"10.1016\/j.path.2018.02.009_bib40","doi-asserted-by":"crossref","first-page":"7584","DOI":"10.3748\/wjg.v21.i24.7584","article-title":"Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: a single center report of 8 cases","volume":"21","author":"Rodrigues","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1016\/j.path.2018.02.009_bib41","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/apt.13159","article-title":"New onset idiosyncratic liver enzyme elevations with biological therapy in inflammatory bowel disease","volume":"41","author":"Shelton","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"15","key":"10.1016\/j.path.2018.02.009_bib42","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1200\/JCO.2005.04.5716","article-title":"Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4","volume":"24","author":"Beck","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.path.2018.02.009_bib43","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s10620-012-2140-5","article-title":"Pathologic changes in ipilimumab-related hepatitis in patients with metastatic melanoma","volume":"57","author":"Kleiner","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"8","key":"10.1016\/j.path.2018.02.009_bib44","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/PAS.0000000000000453","article-title":"Ipilimumab-associated hepatitis: clinicopathologic characterization in a series of 11 cases","volume":"39","author":"Johncilla","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"21","key":"10.1016\/j.path.2018.02.009_bib45","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa1414428","article-title":"Nivolumab and ipilimumab versus ipilimumab in untreated melanoma","volume":"372","author":"Postow","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.path.2018.02.009_bib46","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.msard.2015.08.008","article-title":"Natalizumab-induced hepatic injury: a case report and review of literature","volume":"4","author":"Antezana","year":"2015","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"10.1016\/j.path.2018.02.009_bib47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","article-title":"Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population","volume":"33","author":"Boberg","year":"1998","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"10.1016\/j.path.2018.02.009_bib48","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","article-title":"Drug-induced autoimmune hepatitis: clinical characteristics and prognosis","volume":"51","author":"Bjornsson","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.path.2018.02.009_bib49","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00535-015-1131-7","article-title":"An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis","volume":"51","author":"Hisamochi","year":"2016","journal-title":"J\u00a0Gastroenterol"},{"issue":"3","key":"10.1016\/j.path.2018.02.009_bib50","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.24481","article-title":"The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury","volume":"54","author":"Suzuki","year":"2011","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.path.2018.02.009_bib51","first-page":"487","article-title":"Acute temozolomide induced liver injury: mixed type hepatocellular and cholestatic toxicity","volume":"79","author":"Aygun","year":"2016","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.path.2018.02.009_bib52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13256-016-0804-z","article-title":"Temozolomide-induced biliary ductopenia: a case report","volume":"10","author":"Balakrishnan","year":"2016","journal-title":"J\u00a0Med Case Rep"},{"issue":"12","key":"10.1016\/j.path.2018.02.009_bib53","doi-asserted-by":"crossref","first-page":"e476","DOI":"10.1097\/MD.0000000000000476","article-title":"Severe cholestatic hepatitis due to temozolomide: an adverse drug effect to keep in mind. Case report and review of literature","volume":"94","author":"Grieco","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.path.2018.02.009_bib54","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s10620-012-2493-9","article-title":"Clinical and histological features of idiosyncratic acute liver injury caused by temozolomide","volume":"58","author":"Grant","year":"2013","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.path.2018.02.009_bib55","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/hep.28967","article-title":"Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements","volume":"65","author":"Bonkovsky","year":"2017","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.path.2018.02.009_bib56","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/ajg.2015.283","article-title":"Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury","volume":"110","author":"Fontana","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.path.2018.02.009_bib57","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/1574886309666140827122735","article-title":"Paracetamol-induced Stevens Johnson syndrome and cholestatic hepatitis","volume":"10","author":"Slim","year":"2015","journal-title":"Curr Drug Saf"},{"issue":"1","key":"10.1016\/j.path.2018.02.009_bib58","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1017\/neu.2014.28","article-title":"Agomelatine-induced liver injury in a patient with choledocholithiasis","volume":"27","author":"Eder","year":"2015","journal-title":"Acta Neuropsychiatr"},{"issue":"1","key":"10.1016\/j.path.2018.02.009_bib59","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1002\/phar.1677","article-title":"Anakinra-induced acute liver failure in an adolescent patient with Still's disease","volume":"36","author":"Taylor","year":"2016","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.path.2018.02.009_bib60","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/hep.27900","article-title":"Cholestatic liver injury secondary to artemisinin","volume":"62","author":"Kumar","year":"2015","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.path.2018.02.009_bib61","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jhep.2014.11.019","article-title":"Acute liver failure following atorvastatin dose escalation: is there a threshold dose for idiosyncratic hepatotoxicity?","volume":"62","author":"Carrascosa","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"15","key":"10.1016\/j.path.2018.02.009_bib62","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.3748\/wjg.v22.i15.4062","article-title":"Atypical onset of bicalutamide-induced liver injury","volume":"22","author":"Yun","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.path.2018.02.009_bib63","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jclinane.2016.01.035","article-title":"Bupivacaine drug-induced liver injury: a case series and brief review of the literature","volume":"32","author":"Chintamaneni","year":"2016","journal-title":"J\u00a0Clin Anesth"},{"issue":"3","key":"10.1016\/j.path.2018.02.009_bib64","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s12328-016-0648-5","article-title":"Autoimmune hepatitis following drug-induced liver injury in an elderly patient","volume":"9","author":"Kumagai","year":"2016","journal-title":"Clin J Gastroenterol"},{"issue":"1","key":"10.1016\/j.path.2018.02.009_bib65","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1097\/MJT.0b013e318293b0d6","article-title":"Acute hepatitis associated with clopidogrel: a case report and review of the literature","volume":"22","author":"Pisapia","year":"2015","journal-title":"Am J Ther"},{"issue":"2","key":"10.1016\/j.path.2018.02.009_bib66","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/liv.12899","article-title":"Cyproterone acetate induces a wide spectrum of acute liver damage including corticosteroid-responsive hepatitis: report of 22 cases","volume":"36","author":"Bessone","year":"2016","journal-title":"Liver Int"},{"issue":"24","key":"10.1016\/j.path.2018.02.009_bib67","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.2169\/internalmedicine.55.7347","article-title":"Daclatasvir and asunaprevir combination therapy-induced hepatitis and cholecystitis with coagulation disorder due to hypersensitivity reactions","volume":"55","author":"Miyashima","year":"2016","journal-title":"Intern Med"},{"issue":"3","key":"10.1016\/j.path.2018.02.009_bib68","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/hep.28403","article-title":"Febuxostat-induced acute liver injury","volume":"63","author":"Bohm","year":"2016","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.path.2018.02.009_bib69","doi-asserted-by":"crossref","first-page":"e1211","DOI":"10.1097\/MJT.0000000000000310","article-title":"Acute cholestatic liver injury from hydralazine intake","volume":"23","author":"Harati","year":"2016","journal-title":"Am J Ther"},{"issue":"2","key":"10.1016\/j.path.2018.02.009_bib70","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1665-2681(19)30792-6","article-title":"Interferon beta 1a-induced severe autoimmune hepatitis in patients with multiple sclerosis: report of two cases and review of the literature","volume":"14","author":"Villamil","year":"2015","journal-title":"Ann Hepatol"},{"issue":"2","key":"10.1016\/j.path.2018.02.009_bib71","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3350\/cmh.2015.0037","article-title":"Drug-induced liver injury caused by iodine-131","volume":"22","author":"Kim","year":"2016","journal-title":"Clin Mol Hepatol"},{"issue":"4","key":"10.1016\/j.path.2018.02.009_bib72","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3350\/cmh.2016.0023","article-title":"A\u00a0case of levocetirizine-induced liver injury","volume":"22","author":"Jung","year":"2016","journal-title":"Clin Mol Hepatol"},{"issue":"36","key":"10.1016\/j.path.2018.02.009_bib73","doi-asserted-by":"crossref","first-page":"10475","DOI":"10.3748\/wjg.v21.i36.10475","article-title":"Autoimmune-like hepatitis during masitinib therapy in an amyotrophic lateral sclerosis patient","volume":"21","author":"Salvado","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.path.2018.02.009_bib74","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-205857","article-title":"An unusual cause of febrile hepatitis","volume":"2015","author":"Stelzer","year":"2015","journal-title":"BMJ Case Rep"},{"issue":"4","key":"10.1016\/j.path.2018.02.009_bib75","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2169\/internalmedicine.56.7669","article-title":"Hepatic sinusoidal obstruction syndrome induced by non-transplant chemotherapy for non-Hodgkin lymphoma","volume":"56","author":"Sakumura","year":"2017","journal-title":"Intern Med"},{"issue":"4","key":"10.1016\/j.path.2018.02.009_bib76","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1590\/1516-3180.2013.7550003","article-title":"Nimesulide-induced fatal acute liver failure in an elderly woman with metastatic biliary adenocarcinoma. A case report","volume":"133","author":"Bernardes","year":"2015","journal-title":"Sao Paulo Med J"},{"issue":"6","key":"10.1016\/j.path.2018.02.009_bib77","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/j.dld.2015.02.010","article-title":"Oral contraceptive-induced hepatic sinusoidal dilatation","volume":"47","author":"Kumar","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.path.2018.02.009_bib78","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jpeds.2015.10.065","article-title":"Sertraline-associated cholestasis and ductopenia consistent with vanishing bile duct syndrome","volume":"169","author":"Conrad","year":"2016","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.path.2018.02.009_bib79","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jhep.2015.07.041","article-title":"Liver toxicity associated with sofosbuvir, an NS5A inhibitor and ribavirin use","volume":"64","author":"Dyson","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.path.2018.02.009_bib80","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/hep.28320","article-title":"Freshwater clam extract supplement-induced acute cholestasis","volume":"63","author":"Yokomori","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.path.2018.02.009_bib81","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5604\/16652681.1184287","article-title":"Acute liver failure associated with Garcinia cambogia use","volume":"15","author":"Corey","year":"2015","journal-title":"Ann Hepatol"},{"issue":"1","key":"10.1016\/j.path.2018.02.009_bib82","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4166\/kjg.2015.65.1.52","article-title":"A\u00a0case of nodular regenerative hyperplasia of the liver combined with toxic hepatitis","volume":"65","author":"Jin","year":"2015","journal-title":"Korean J Gastroenterol"},{"issue":"1","key":"10.1016\/j.path.2018.02.009_bib83","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ajg.2016.02.002","article-title":"Khat-induced liver injuries: a report of two cases","volume":"17","author":"Alhaddad","year":"2016","journal-title":"Arab J Gastroenterol"},{"issue":"1","key":"10.1016\/j.path.2018.02.009_bib84","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4102\/phcfm.v8i1.1124","article-title":"Khat chewing and cirrhosis in Somaliland: case series","volume":"8","author":"Mahamoud","year":"2016","journal-title":"Afr J Prim Health Care Fam Med"},{"issue":"1","key":"10.1016\/j.path.2018.02.009_bib85","first-page":"26","article-title":"A\u00a0case of hepatotoxicity related to kombucha tea consumption","volume":"69","author":"Gedela","year":"2016","journal-title":"S\u00a0D Med"},{"issue":"3","key":"10.1016\/j.path.2018.02.009_bib86","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12328-016-0638-7","article-title":"Drug-induced liver injury with autoimmune features complicated with hemophagocytic syndrome","volume":"9","author":"Hayashi","year":"2016","journal-title":"Clin J Gastroenterol"},{"issue":"1","key":"10.1016\/j.path.2018.02.009_bib87","first-page":"53","article-title":"Ecstasy induced acute hepatic failure. Case reports","volume":"78","author":"Atayan","year":"2015","journal-title":"Acta Gastroenterol Belg"},{"issue":"1","key":"10.1016\/j.path.2018.02.009_bib88","doi-asserted-by":"crossref","first-page":"e2445","DOI":"10.1097\/MD.0000000000002445","article-title":"Recurrent acute liver failure because of acute hepatitis induced by organic solvents: a case report","volume":"95","author":"Ito","year":"2016","journal-title":"Medicine (Baltimore)"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918118300096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918118300096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T11:02:09Z","timestamp":1751626929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918118300096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":88,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S1875918118300096"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2018.02.009","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent Advances in the Histopathology of Drug-Induced Liver Injury","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2018.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}